These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8900302)

  • 1. A new oral formulation of cyclosporine for early oral immunosuppressive therapy in liver transplant recipients.
    Winkler M; Haller G; Oldhafer K; Bechstein WO; Kattner A; Maibücher A; Färber L; Ringe B; Christians U; Neuhaus P; Pichlmayr R
    Transplantation; 1996 Oct; 62(8):1063-8. PubMed ID: 8900302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of an oral solution of the microemulsion formulation of cyclosporine in maintenance pediatric liver transplant recipients.
    Dunn S; Cooney G; Sommerauer J; Lindsay C; McDiarmid S; Wong RL; Chang CT; Smith HT; Choc MG
    Transplantation; 1997 Jun; 63(12):1762-7. PubMed ID: 9210501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microemulsion formulation of cyclosporine in pediatric liver transplantation.
    Alberti D; Wallemacq P; Falchetti D; de Ville de Goyet J; Rigamonti W; Panzali A; Sokal E; Otte JB; Reding R
    Transplantation; 1996 Feb; 61(3):512-4. PubMed ID: 8610371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption characteristics of a microemulsion formulation of cyclosporine in de novo pediatric liver transplant recipients.
    Dunn SP; Cooney GF; Kulinsky A; Falkenstein K; Pierson A; Elder CA; Meligeni J
    Transplantation; 1995 Dec; 60(12):1438-42. PubMed ID: 8545871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetic model to predict steady-state exposure to once-daily cyclosporin microemulsion in renal transplant recipients.
    Schädeli F; Marti HP; Frey FJ; Uehlinger DE
    Clin Pharmacokinet; 2002; 41(1):59-69. PubMed ID: 11825097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of two oral cyclosporin a formulations in clinically stable heart-transplant patients.
    Baraldo M; Pea F; Poz D; Furlanut M
    Pharmacol Res; 2001 Jun; 43(6):547-51. PubMed ID: 11419964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cyclosporine microemulsion C2 monitoring in Chinese adult liver transplant recipients: a preliminary randomized control trial].
    Chen G; He Y; Wang HZ; Lu Q; Yang SZ; Yang ZY; Dong JH
    Zhonghua Wai Ke Za Zhi; 2005 Oct; 43(19):1243-7. PubMed ID: 16271221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of cyclosporine for liver transplantation.
    Lilly LB; Grant D
    Transplant Proc; 2004 Mar; 36(2 Suppl):267S-270S. PubMed ID: 15041351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation.
    Canadian Neoral Renal Transplantation Study Group
    Transplantation; 2001 Sep; 72(6):1024-32. PubMed ID: 11579295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of cyclosporine microemulsion (neoral) versus conventional cyclosporine in liver transplantation: MILTON study. Multicentre International Study in Liver Transplantation of Neoral.
    Otto MG; Mayer AD; Clavien PA; Cavallari A; Gunawardena KA; Mueller EA
    Transplantation; 1998 Dec; 66(12):1632-40. PubMed ID: 9884251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to convert from traditional cyclosporine to the microemulsion formulation in stable renal transplant patients?
    Gaspari F; Perico N; Pisoni R; Anedda MF; Signorini O; Caruso R; Gotti E; Remuzzi G
    Clin Transplant; 1998 Oct; 12(5):379-90. PubMed ID: 9787945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A comparative randomized prospective multicenter study of Sandimmune vs Neoral in liver transplantation].
    Roy A; Grant DR; Kneteman NM; Tchervenkov JI; Levy GA; Tan A; Hendricks L
    Ann Chir; 1998; 52(8):716-21. PubMed ID: 9846420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-adjusted cyclosporine c2 in a patient with jejunoileal bypass as compared to seven other liver transplant recipients.
    Chenhsu RY; Wu Y; Katz D; Rayhill S
    Ther Drug Monit; 2003 Dec; 25(6):665-70. PubMed ID: 14639052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine--results at six months after transplantation.
    Eisen HJ; Hobbs RE; Davis SF; Laufer G; Mancini DM; Renlund DG; Valantine H; Ventura H; Vachiery JL; Bourge RC; Canver CC; Carrier M; Costanzo MR; Copeland J; Dureau G; Frazier OH; Dorent R; Hauptman PJ; Kells C; Master R; Michaud JL; Paradis I; Smith A; Vanhaecke J; Mueller EA
    Transplantation; 1999 Sep; 68(5):663-71. PubMed ID: 10507486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion and pharmacokinetic studies of a microemulsion formulation of cyclosporine in pediatric liver transplant patients.
    D'Agostino D; Gimenez M; Yamaguchi B; Glancszpigel R; Vinuesa F; Gamba M; Ciardullo M; de Santibaes E
    Transplantation; 1996 Oct; 62(8):1068-71. PubMed ID: 8900303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretransplant test-dose pharmacokinetic profiles: cyclosporine microemulsion versus corn oil-based soft gel capsule formulation.
    Chueh SC; Kahan BD
    J Am Soc Nephrol; 1998 Feb; 9(2):297-304. PubMed ID: 9527407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporin. A review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral).
    Noble S; Markham A
    Drugs; 1995 Nov; 50(5):924-41. PubMed ID: 8586033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of bile on cyclosporin absorption from microemulsion formulation in primary liver transplant recipients.
    Winkler M; Ringe B; Oldhafer K; Kattner A; Färber L; Maibücher A; Wonigeit K; Pichlmayr R
    Transpl Int; 1995; 8(4):324-6. PubMed ID: 7546157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination.
    Gonwa TA; Hricik DE; Brinker K; Grinyo JM; Schena FP;
    Transplantation; 2002 Dec; 74(11):1560-7. PubMed ID: 12490789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Achieving adequate cyclosporine exposure in liver transplant recipients: a novel strategy for monitoring and dosing using intravenous therapy.
    Lück R; Böger J; Kuse E; Klempnauer J; Nashan B
    Liver Transpl; 2004 May; 10(5):686-91. PubMed ID: 15108262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.